Sysmex Corporation

Tomokazu Yoshida

Hideki Ishihara

Keiichiro Shohmi

Masaki Shibayama

Sachiyo Tada

Kazuki Nakabayashi

Koichi Yamagata

Amane Harada

Masatoshi Yamasaki

Keiichiro Shomi

Tomoko Ohyama

Keigo Gohda

Shigeyuki Tamura

Masahiro Nishida

Jun Sato

A method for detecting an analyte in a sample is described herein. The method comprises: preparing a complex immobilized solid phase comprising a solid phase and a complex on the solid phase; the complex comprising an analyte and a signal emitting substance; treating the complex immobilized solid phase with a blocking agent; and detecting the analyte based on a signal emitted from the signal emitting substance of the complex immobilized solid phase.

Method for detecting protein

A kit for preparing a cancer cell detection sample which is highly safe, simple, and high in precision, and can detect a cancer cell quantitatively, and a kit for cancer cell detection using the same, as well as a method for diagnosing cancer using those kits, and a method for preparing a sample for cancer cell detection are provided. A kit for preparing a detection sample for detecting a cancer cell of the present invention, comprising a test container having an opening for receiving a biological sample collected from a subject, and a reagent inclusion part for accommodating a reagent containing a virus, a seal part for sealing the reagent inclusion part of the test container, a cap for closing the opening, and an opener for breaking the seal part.

Kit for preparing cancer cell detection sample and kit for cancer cell detection using the same

The present invention provides a method for determining susceptibility to an anthracycline anticancer agent, comprising the steps consisting of detecting the expression of activated Akt in a cancer cell or cancer tissue and determining the susceptibility of the cancer cell or cancer tissue to the anthracycline anticancer agent on the basis of the detection result. The method for determining the susceptibility to an anticancer agent can be used in objective and accurate determination of the susceptibility of a cancer cell or cancer tissue to an anthracycline anticancer agent without imposing a heavy burden on a patient.

Method for determining the efficacy of an anthracycline anticancer agent

A method for determining the activity of a cell cycle regulatory factor comprising the steps of:

Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same

In detecting a nucleic acid by using the nucleic acid amplification method, it is intended to shorten the time required for the measurement so as to systematically and efficiently examine a gene, etc. To achieve this object, use is made of a method of directly amplifying a nucleic acid by treating a collected biological sample wherein a means of inhibiting the degradation activity of the nucleic acid is introduced during or after the step of homogenizing the biological sample and thus the nucleic acid is directly amplified without isolating/purifying the nucleic acid component from the biological sample. In this method, the means of inhibiting the degradation activity of the nucleic acid is introduced at an acidic pH value (more specifically, from pH 2.5 to pH 5) with the use of a salt interacting with a substance inhibiting the nucleic acid amplification reaction and/or the nucleic acid component so as to directly amplify the nucleic acid without isolating/purifying the nucleic acid component.

Method and system for detection of nucleic acids

Growing community of inventors

Kobe, Japan

Tomokazu Yoshida